Contact
Kirkham Young Ltd.
7 Watch Oak Business Centre, Chain Lane, Battle, East Sussex
TN33 0GB
- T
- +44 (0)1424 777745
- F
- +44 (0)1424 777746
- E
- info@kirkhamyoung.co.uk
Job creation focused on at Biotech and Pharma Conference
09/12/2011
The Financial Times Biotech and Pharma Conference, which was held earlier this week, highlighted the important role the life sciences sector plays in boosting the UK economy.
The Prime Minister spoke at the event, calling the sector a ‘jewel in the crown of our economy’, which makes a vast contribution to healthcare and puts the UK on the map as a medical force to be reckoned with.
He said that, whilst the UK makes up just one per cent of the world's population, the country produces eight per cent of the world’s scientific papers.
However, one area that does need to be boosted is the number of clinical trials to evaluate new medicines and medical equipment, as that number has been falling over recent years. Whereas in 2002, seven per cent of all global clinical trials were based in the UK, that had dropped to just two per cent by 2007.
Cameron also confirmed that a focus must be placed on the recruitment process for medical sales jobs and hospital sales jobs in order to bring the UK in line with other countries such as France, Poland and the Czech Republic, where clinical trials are increasing year on year.
He cited the recent closure of the Sandwich, Kent-based Pfizer pharmaceutical research facility as a ‘blow’ to UK science graduates who were looking for medical or scientific sales jobs.
The Prime Minister spoke at the event, calling the sector a ‘jewel in the crown of our economy’, which makes a vast contribution to healthcare and puts the UK on the map as a medical force to be reckoned with.
He said that, whilst the UK makes up just one per cent of the world's population, the country produces eight per cent of the world’s scientific papers.
However, one area that does need to be boosted is the number of clinical trials to evaluate new medicines and medical equipment, as that number has been falling over recent years. Whereas in 2002, seven per cent of all global clinical trials were based in the UK, that had dropped to just two per cent by 2007.
Cameron also confirmed that a focus must be placed on the recruitment process for medical sales jobs and hospital sales jobs in order to bring the UK in line with other countries such as France, Poland and the Czech Republic, where clinical trials are increasing year on year.
He cited the recent closure of the Sandwich, Kent-based Pfizer pharmaceutical research facility as a ‘blow’ to UK science graduates who were looking for medical or scientific sales jobs.
RSS
